Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

Teva sells UK and Ireland assets to Intas Pharma for £603m

Teva sells UK and Ireland assets to Intas Pharma for £603m Teva has followed through on a pledge to sell off various assets in the UK and Ireland following its $40bn takeover of Actavis Generics, which closed in August. ... He also said the company has "a clear plan for the continuation and development of the

Deal Watch August 2016

Deal Watch August 2016 Apr 14 / Hostile. Valeant. Allergan. $54bn. Allergan sold to Actavis for $66bn. ... Allergan sells to Actavis not Valeant. As far as we know, Sanofi did not have any business relationships with Medivation unlike Pfizer who had a deal running from 2008 to

Teva acquires Allergan’s generics operations in $38.8bn deal

Teva acquires Allergan’s generics operations in $38.8bn deal Teva Pharmaceutical Industries, the global leader in generic drugs sales, has further bolstered its market dominance with the purchase of Allergan's generics business, Actavis Generics. ... Erez Vigodman, president and chief executive at Teva, said that

AZ gets EU green light for new antibiotic Zavicefta

AZ gets EU green light for new antibiotic Zavicefta AZ and Actavis are also testing avibactam in combination with other beta lactam antibiotics, with phase III trials ongoing looking at the drug alongside aztreonam and ceftaroline.

Merck starts pivotal trials of new antibiotic combination

Merck starts pivotal trials of new antibiotic combination The combination has also been approved in the US - where it is sold by Actavis - as Avycaz.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics